Fluoxetine for Compulsive Grooming/Skin Picking with Anxiety and Depression
Fluoxetine is an appropriate and evidence-based choice for treating compulsive grooming and skin picking, particularly when accompanied by anxiety and depression. This SSRI has FDA approval for obsessive-compulsive disorder (OCD) and demonstrated efficacy in controlled trials specifically for pathologic skin picking 1.
Why Fluoxetine Works for This Presentation
The compulsive grooming and picking you describe shares phenomenological overlap with body-focused repetitive behaviors (BFRBs) and OCD-spectrum disorders. Fluoxetine addresses multiple components of your presentation simultaneously:
Skin picking behavior: Two controlled trials demonstrated fluoxetine's superiority over placebo for pathologic skin picking 2, 3. In the double-blind trial, responders maintained improvement when continued on fluoxetine, while those switched to placebo relapsed to baseline 3.
Anxiety and depression: Fluoxetine effectively treats comorbid anxiety and depressive symptoms, which are present in approximately 70% of patients with body-focused repetitive behaviors 4. One study of 123 patients with major depression and comorbid anxiety disorders showed 53% response rates and significant improvement in both depression and anxiety symptoms 5.
Dosing Strategy
Start with 10-20 mg daily for the first week, then increase to 20 mg daily 1. This lower initial dose minimizes early anxiety/agitation that can occur with SSRIs 6, 1.
For compulsive behaviors specifically:
- Target dose: 40-60 mg daily for OCD-spectrum symptoms including skin picking 1, 7
- Higher doses (up to 80 mg/day) have been used successfully in open trials for trichotillomania and skin picking 2, 8
- Allow 8-12 weeks at therapeutic dose before assessing full efficacy, as OCD-spectrum symptoms respond more slowly than depression 9, 1, 7
Fluoxetine's long half-life (3-4 weeks for discontinuation) permits once-daily dosing and provides a buffer against missed doses 6.
Critical Monitoring Points
Watch for these specific adverse effects:
- Behavioral activation/agitation in the first 2-4 weeks—paradoxically, this can predict good response 1, 7
- Suicidal ideation, particularly if you're under age 25 (black box warning) 1
- Nausea, insomnia, sexual dysfunction (common but usually manageable) 6
- Rare but serious: serotonin syndrome if combined with other serotonergic drugs, QT prolongation in susceptible individuals 10, 1
Important Caveats
The distinction between skin picking in BDD versus excoriation disorder matters clinically 4. In BDD, picking attempts to "fix" perceived appearance flaws; in excoriation disorder, picking isn't appearance-driven. Your clinician should clarify this, as it affects treatment approach—though fluoxetine treats both conditions.
If you have CYP2D6 poor metabolizer genetics (affects 7-10% of Caucasians), fluoxetine levels can be 3.9-11.5 fold higher, increasing toxicity risk 10. While routine genetic testing isn't standard, consider it if you experience severe side effects at low doses.
Treatment Timeline
- Week 1-2: Start low dose, monitor for tolerability
- Week 2-4: Increase to 20 mg if tolerated
- Week 4-8: Consider increasing to 40-60 mg for compulsive behaviors
- Week 8-12: Assess response; full effect may take this long 9, 1
- Maintenance: Continue 12-24 months minimum after remission 9
Combination with cognitive-behavioral therapy (CBT) targeting skin picking would be ideal 6, though medication alone has demonstrated efficacy 2, 3.
The evidence supports fluoxetine as first-line pharmacotherapy for your symptom constellation, with the caveat that response should be monitored systematically using standardized measures rather than subjective impression alone 6.